These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 3330648)
1. A manno-protein antigen of Candida albicans cell wall induces generation of anti-tumor cytotoxicity in human peripheral blood lymphocytes. A comparative study between healthy donors and glioma bearing patients. Ausiello C; Maleci A; Spagnoli GC; Palma C; Boccanera M; Gagliardi F; Casciani CU; Cassone A Ann Ist Super Sanita; 1987; 23(4):835-40. PubMed ID: 3330648 [No Abstract] [Full Text] [Related]
2. A comparison between interleukin-2- and mannoprotein-activated MHC-unrestricted, killer cells in human peripheral blood mononuclear cells. Palma C; Ausiello C; Spagnoli GC; Casalinuovo I; Cassone A; Casciani CU J Chemother; 1989 Jul; 1(4 Suppl):449-51. PubMed ID: 16312480 [No Abstract] [Full Text] [Related]
3. The characteristics of human NKT cells in lung cancer--CD1d independent cytotoxicity against lung cancer cells by NKT cells and decreased human NKT cell response in lung cancer patients. Konishi J; Yamazaki K; Yokouchi H; Shinagawa N; Iwabuchi K; Nishimura M Hum Immunol; 2004 Nov; 65(11):1377-88. PubMed ID: 15556688 [TBL] [Abstract][Full Text] [Related]
4. Autologous natural killer cell therapy for human recurrent malignant glioma. Ishikawa E; Tsuboi K; Saijo K; Harada H; Takano S; Nose T; Ohno T Anticancer Res; 2004; 24(3b):1861-71. PubMed ID: 15274367 [TBL] [Abstract][Full Text] [Related]
5. Mannoprotein-induced anti-U937 cell cytotoxicity in peripheral blood mononuclear cells from uninfected or HIV-infected subjects: role of interferon-gamma and tumor necrosis factor-alpha. Gomez MJ; Torosantucci A; Quinti I; Testa U; Peschle C; Cassone A Cell Immunol; 1993 Dec; 152(2):530-43. PubMed ID: 8258154 [TBL] [Abstract][Full Text] [Related]
6. Perforin-mediated lysis of tumor cells by Mycobacterium bovis Bacillus Calmette-Guérin-activated killer cells. Brandau S; Suttmann H; Riemensberger J; Seitzer U; Arnold J; Durek C; Jocham D; Flad HD; Böhle A Clin Cancer Res; 2000 Sep; 6(9):3729-38. PubMed ID: 10999767 [TBL] [Abstract][Full Text] [Related]
7. NK cells stimulated with IL-15 or CpG ODN enhance rituximab-dependent cellular cytotoxicity against B-cell lymphoma. Moga E; Alvarez E; Cantó E; Vidal S; Rodríguez-Sánchez JL; Sierra J; Briones J Exp Hematol; 2008 Jan; 36(1):69-77. PubMed ID: 17959301 [TBL] [Abstract][Full Text] [Related]
8. Generation and characterization of cytotoxic activity against tumor cell lines in human peripheral blood mononuclear cells stimulated "in vitro" by a glucomannan-protein preparation of Candida albicans. Ausiello CM; Spagnoli GC; Antonelli G; Malavasi F; Dianzani F; Casciani CU; Cassone A J Biol Regul Homeost Agents; 1987; 1(2):59-68. PubMed ID: 3142217 [TBL] [Abstract][Full Text] [Related]
9. Effect of streptococcal lyzate OK-432 on peripheral blood mononuclear cells in gastric cancer patients. Nakayama F; Iwagaki H; Gouchi A; Hizuta A; Isozaki H; Takakura N; Tanaka N J Med; 1998; 29(3-4):199-215. PubMed ID: 9865458 [TBL] [Abstract][Full Text] [Related]
10. X-irradiation to human malignant glioma cells enhances the cytotoxicity of autologous killer lymphocytes under specific conditions. Ishikawa E; Tsuboi K; Saijo K; Takano S; Ohno T Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1505-12. PubMed ID: 15275738 [TBL] [Abstract][Full Text] [Related]
11. Effect of benzo[a]phenothiazines on natural killer cell activity of human peripheral blood mononuclear cells. Petri IB; Szekeres E; Berek I; Molnár J; Sakagami H; Motohashi N Anticancer Res; 1993; 13(6A):2273-5. PubMed ID: 8297145 [TBL] [Abstract][Full Text] [Related]
12. Interleukin-18 (IL-18) synergizes with IL-2 to enhance cytotoxicity, interferon-gamma production, and expansion of natural killer cells. Son YI; Dallal RM; Mailliard RB; Egawa S; Jonak ZL; Lotze MT Cancer Res; 2001 Feb; 61(3):884-8. PubMed ID: 11221875 [TBL] [Abstract][Full Text] [Related]
13. Activation of human effector cells by a tumor reactive recombinant anti-ganglioside GD2 interleukin-2 fusion protein (ch14.18-IL2). Hank JA; Surfus JE; Gan J; Jaeger P; Gillies SD; Reisfeld RA; Sondel PM Clin Cancer Res; 1996 Dec; 2(12):1951-9. PubMed ID: 9816154 [TBL] [Abstract][Full Text] [Related]
14. Experimental study on the treatment of intracerebral glioma xenograft with human cytokine-induced killer cells. Wang P; Yu JP; Gao SY; An XM; Ren XB; Wang XG; Li WL Cell Immunol; 2008; 253(1-2):59-65. PubMed ID: 18522858 [TBL] [Abstract][Full Text] [Related]
15. [Effects of TCGF (T-cell growth factor) on experimental malignant glioma-specific killer T-cell]. Yamasaki T; Yamashita J; Handa H; Namba Y; Hanaoka M No Shinkei Geka; 1984 Feb; 12(2):141-50. PubMed ID: 6609319 [TBL] [Abstract][Full Text] [Related]
16. Enhancement of immune response by phenothiazine administration in vivo. Ghosh N; Chattopadhyay U In Vivo; 1993; 7(5):435-40. PubMed ID: 7906554 [TBL] [Abstract][Full Text] [Related]
17. [Experimental studies on the treatment of recurrent gliomas]. Yamada M; Shimizu K; Okamoto Y; Miyao Y; Matsui Y; Tsuda N; Mogami H Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1890-5. PubMed ID: 3496051 [TBL] [Abstract][Full Text] [Related]
18. A sequential scanning of the immune efficiency in astrocytoma (Grade I to Grade Iii), meningioma and secondary glioma patients with and without therapeutic scheduling. Bhattacharjee M; Bose I; Sarkar P; Banerjee C; Dutta S; Ghosh A; Mukherjee J; Acharya S; Goswami S; Mazumdar A; Chaudhuri S; Chaudhuri S Cancer Invest; 2006; 24(5):502-13. PubMed ID: 16939959 [TBL] [Abstract][Full Text] [Related]
19. Toxicity to Candida albicans mediated by human serum and peripheral blood mononuclear cells. Bliss JM; Laforce-Nesbitt SS FEMS Immunol Med Microbiol; 2006 Apr; 46(3):452-60. PubMed ID: 16553821 [TBL] [Abstract][Full Text] [Related]
20. Generation of a human leukocyte antigen-A24-restricted antitumor cell with the use of SART-1 peptide and dendritic cells in patients with malignant brain tumors. Yoshida S; Tanaka R J Lab Clin Med; 2004 Oct; 144(4):201-7. PubMed ID: 15514588 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]